Showing 15,041 - 15,060 results of 105,386 for search '(( 5 ((mean decrease) OR (a decrease)) ) OR ( e ((fold decrease) OR (point decrease)) ))', query time: 1.70s Refine Results
  1. 15041
  2. 15042
  3. 15043
  4. 15044
  5. 15045
  6. 15046
  7. 15047
  8. 15048
  9. 15049
  10. 15050
  11. 15051
  12. 15052
  13. 15053
  14. 15054
  15. 15055
  16. 15056
  17. 15057

    DataSheet_5_Integration of single-cell RNA sequencing and bulk RNA sequencing to reveal an immunogenic cell death-related 5-gene panel as a prognostic model for osteosarcoma.pdf by Jiaqi Yang (4380466)

    Published 2022
    “…</p>Conclusions<p>Overall, ICD represented a protective factor against OS, and our 5-gene risk panel serving as a biomarker could effectively evaluate the prognostic risk in patients with OS.…”
  18. 15058
  19. 15059

    SERCA is required for Ca<sup>2</sup>+ transients at E5.5. by Matthew J. Stower (22379321)

    Published 2025
    “…DMSO treated embryos had a significant decrease in transients (one-way ANOVA, <i>p</i> ≤ 0.001, followed by Tukey’s HSD Test; baseline vs. 30 min DMSO <i>p</i> > 0.05), but thapsigargin almost completely abolished transients to a significant effect (one-way ANOVA, <i>p</i> ≤ 0.001, followed by Tukey’s HSD Test, baseline vs. 30 min 10 nM thapsigargin <i>p</i> ≤ 0.001), that was significantly lower than DMSO controls (one-way ANOVA, <i>p</i> ≤ 0.001, followed by Tukey’s HSD Test, 30 min DMSO vs. 30 min 10 nM thapsigargin: <i>p</i> ≤ 0.001). …”
  20. 15060

    Decreased phosphorylation of GSK3β-Ser9 in thrombin stimulated PP1cγ<sup>−/−</sup> platelets. by Francisca C. Gushiken (368549)

    Published 2013
    “…<p>(<b>A</b>). Platelet lysate from resting (0) and thrombin activated (0.005, 0.01 and 0.02 U/ml) was separated on an SDS-PAGE and immunoblotted with antibodies to AKT-Ser473, GSK3β- Ser9 and AKT (total). …”